So measurement of CRP in IBD patients for evaluation of the efficacy of treatment on inflammation is a good criteria, such that its decline showed positive effects of therapies and increased values are due to failure in immuno-regulation (24). This evidence concerns the gene CRP and inflammatory bowel disease.